The Life Prolongation and QOL Improvement Effect of Rice Bran Arabinoxylan Derivative (MGN-3, BioBran) for Progressive Cancer

  • Kihachiro Takahara and Kamataro Sano
  • 2004

The present study was designed to deremine whether or not the administration of MGN-3 coud have its apothanasia effect and improve the QOL for 205 progressive and partially metastasized cancer patients in late III-IV stages after surgery. MGN-3 is a rice bran arabinoxylan derivative and known to have immunomodulation activity. The participants in this clinical study are hospitalized patients in our clinic treated with complementary alternative medicines (we call it "Non-Conventional Therapy") and anticancer medicines with lesser side effects. The 205 patients hospitalized for 6 months were grouped into two groups, viz, 109 patients (control group) treated with our standard complementary alternative medicines, and 96 patients who were further given MGN-3 (MGN-3 group) for one year and a half. 

All the patients were measured for natural killer activity as an indication for the variation of immunoparameters. Simultaneously, the QOL of the patients was also checked. The NK cell activities of the patients after surgery were low on average; however, by the administration of MGN-3, NK activity was observed to increase and the apothanasia ratio aslo increased; the higher the patient NK activity is, the higher the apothanasia ratio was observed to rise. The above findings indicate that NK activity can be used as a pathological index of progressive cancers. QOL improvement was also observed with the adminstration of MGN-3

Subscribe to Our Newsletter
Be Updated on latest research!

We use cookies to improve your experience on our website. For more details see our cookie policy.

Like many other websites, we use cookies to provide enhanced functionality and track the usage of our websites with Google Analytics, and some of our third-party advertisers might use them to deliver adverts tailored to what they think you might be interested in.

What are cookies?

Cookies are small text files which can be sent to browser when you visit websites and saved to your device (computer or other device with Internet access, i.e. smartphone or tablet). Cookies are saved in the folder for files of your browser. Cookies usually contain the name of the website they come from and the date of origin. Upon your next visit the browser loads cookies again and sends these information back to the website which originally created cookies. Cookies we use do not harm your computer.

Using cookies

By using this website you give your consent to using cookies in compliance with your browser settings. If you visit our websites, acceptance of cookies is allowed in your browser, you do not change your browser settings and continue visiting our websites we consider it as accepting our conditions for using cookies.

Why are we using cookies?

Cookies are used to optimally create and constantly improve the quality of our services, adjust them to your interests and needs and improve their structure and contents. We do not use data obtained by using cookies to contact users by mail, e-mail or telephone.

How to change settings of cookies?

Majority of browsers have been originally set to automatically accept cookies. This settings can be changed by blocking cookies or by a notification in case cookies are to be sent to your device. Instructions for changing cookies are available in the option “Help” of every browser. If you use different devices to access websites (e.g. computer, smartphone, tablet), we recommend you to adjust every browser on each of them to your preferences regarding cookies.

Why to keep settings of cookies?

Using cookies and permitting cookies in your browser is your decision. However, in case you change settings of cookies, functionality of some of our websites can be limited and their user comfort reduced.